The Government of Canada and Inuit Tapiriit Kanatami commit to eliminating tuberculosis across Inuit Nunangat by 2030

Active TB cases to be reduced by at least 50% by 2025

March 23, 2018, Ottawa, ON

In 2016, the incidence of tuberculosis (TB) among Inuit in Inuit Nunangat was more than 300 times higher than in the Canadian-born, non-Indigenous population. This staggering and unacceptable reality has been trending upward for the last decade and needs to change.

Today, to mark World TB Day, the Minister of Indigenous Services, Jane Philpott, and the President of Inuit Tapiriit Kanatami (ITK), Natan Obed, announced their commitment to eliminating TB across Inuit Nunangat by 2030, and reduce active TB by at least 50% by 2025. This will be achieved through an Elimination Action Framework led by the previously announced TB Task Force.

Among the first priorities are to prevent deaths related to delays in diagnosis and to eliminate TB disease in young children. Elimination plans in each of the four Inuit regions that make up Inuit Nunangat will be developed and tailored to regional strengths and requirements. Regional plans will include enhanced public health programs and capacity-building within communities to enable earlier diagnosis, leading to earlier treatment of active TB disease and latent TB infection. Awareness efforts will also be undertaken to increase understanding of TB in order to help reduce transmission and address stigmatization.

In order to meet these aggressive target dates, special emphasis will be placed on work to address social inequities and improve Inuit social determinants of health that are closely linked to TB; such as housing, food security and nutrition, access to health services and mental wellness.

The Government of Canada and Inuit Tapiriit Kanatami recognize that a multi-faceted, collaborative, and Inuit-driven approach to eliminating TB is critical to success.

This year’s theme for World TB Day is “Wanted – Leaders for a TB-free World”. The Government of Canada and ITK will work collaboratively as leaders to address the social inequities that allow TB to persist, and to eliminate TB across Inuit Nunangat by 2030.

More information here

Quotes

“I would like to acknowledge the tremendous leadership and support of the Inuit Tapiriit Kanatami, as well as the provincial and territorial governments. The Government of Canada will put every effort behind meeting our commitment to eliminate tuberculosis in Inuit Nunangat by 2030. It should never have taken us so long to get to this day and we are determined to move forward with a strategy that is both community-owned and community-driven and one that addresses the social determinants of health.”

The Honourable Jane Philpott, M.D., P.C., M.P.
 Minister of Indigenous Services

“We can and must eliminate tuberculosis from every Inuit community in Canada. Inuit have suffered from this preventable and curable disease, and the colonial legacy of the Government’s indifference to the overall health and well-being of our communities, for too long. I am proud to make this announcement today with a target for elimination of TB among Inuit.  Inuit leaders will hold Canada to account to ensure that TB, which is rooted in social inequity, is addressed completely and fully.”

Natan Obed
President of Inuit Tapiriit Kanatami

“I am pleased that the Government of Nunavut, with the support of the Government of Canada, the Department of Community and Government Services and other partners, have taken a major step this year towards the elimination of TB from our territory. The operation of a seven-week mobile TB screening clinic in one community is an example of what can be achieved in a short period of time when we all work together. It is my hope that we continue future collaboration that will benefit the health and well-being of Nunavummiut.”

Honourable Pat Angnakak
Minister of Health, Government of Nunavut

“The Nunatsiavut Government is committed to TB elimination and has taken many actions to address this disease in our communities, including initiating the development of a TB elimination plan “End Tuberculosis in Nunatsiavut – From Here to There.  We realize that true elimination will only be achieved with federal and provincial partnerships,  as well as through community engagement and support. Elimination of TB requires very specific actions and strategies, including addressing the social determinants of health, such as housing, food security, social supports and healthy child development.”

President Lampe, Government of Nunatsiavut

“The time is now to make eliminating tuberculosis a collective priority. Never before has there been such a shared commitment to eliminate TB in Canada. This is clear by the level of community leadership and investments underway, as well as the collective will demonstrated across all levels of government and with key national Indigenous organizations. The time is now to support the momentum.”
Dr. Theresa Tam
Canada’s Chief Public Health Officer

“Some communities in Nunavik have experienced significant outbreaks of tuberculosis in the last years. This announcement is a positive step to support our mobilization efforts against tuberculosis with our community leaders to create an Inuit-led strategy. It is my belief that we can eliminate tuberculosis if our regional action plans take into account Inuit history and perspective.”

Minnie Grey, Executive Director of the Nunavik Regional Board of Health and Social Services (NRBHSS)

Quick Facts

• Tuberculosis is a disease that disproportionately affects Inuit and First Nations communities in comparison to the Canadian-born, non-Indigenous population. TB can be treated and cured by taking antibiotics.
• Stigma and discrimination remain crucial barriers to TB care and prevention, as they can cause people to delay seeking testing.
• There is a historical trauma of Inuit leaving their communities to go to sanatoriums to be treated in the south, never to return home that remains a barrier to seeking health care.
• The Government of Canada is committed to supporting and working with Inuit organizations, communities, provincial and territorial health care systems, scientific experts and other partners to eliminate TB as a major public health threat across Inuit Nunangat. This includes addressing the health and socio-economic factors contributing to the high incidence of TB among Inuit.
• Budget 2018 recently announced $27.5 million over five years to support this work in Inuit Nunangat. This includes funding for enhanced prevention, screening, diagnosis and treatment of TB and latent TB infection.
• This is part of the $509.5 million committed in Budget 2018 to work with Inuit and other partners to strengthen public health programs, to collect data through an Inuit Health Survey, to invest in housing to address the significant overcrowding in Inuit communities, and to support employment and job training.
• This is in addition to the $240 million over 10 years announced in Budget 2017 to support housing in Nunavut.
• This winter, the Government of Canada supported the Government of Nunavut’s deployment of a mobile screening clinic to a Nunavut community in response to a local TB outbreak. More than 40 health care providers from federal and provincial health systems provided assistance. Since February 2018, the clinic screened over 90% of the population eligible for testing (individuals who were not undergoing TB treatment or had not been previously tested). The results from this mobile clinic will be reviewed and incorporated into future initiatives to reduce TB across Inuit Nunangat.

Associated Links

Tuberculosis Task Force

Inuit-Specific Tuberculosis Strategy

Health Canada – Tuberculosis

First Nations and Inuit Health – Tuberculosis

Canada Communicable Disease Report

ITK Social Inequities Infographic

You can subscribe to receive our news releases and speeches via RSS feeds. For more information or to subscribe, visit www.aandc.gc.ca/subscriptions.

ᐊᐃᑦᑑᑕᐅᓲᖅ ᐳᕙᓪᓗᓐᓇᖅᑐᖅ (TB) ᐱᑕᖃᕈᓐᓃᖅᑎᑕᐅᔪᒫᖅᑐᖅ 50 ᐳᓴᓐᑎᒥ ᑎᑭᓪᓗᒍ 2025

2016-ᒥ, ᐳᕙᓪᓕᓐᓂᖏᑦ (TB) ᐃᓄᓐᓂᒃ ᐃᓄᐃᑦ ᓄᓇᖓᓂ ᐊᒥᓲᓂᖅᓴᐅᓚᐅᖅᑐᑦ 300-ᖏᖅᓱᕐᓗᒍ ᑕᐃᒃᑯᓂᖓ ᑲᓇᑕᒥ ᐃᓅᓂᑰᔪᓂ, ᓄᓇᖃᖅᑳᖅᓯᒪᙱᑦᑐᓂ. ᑖᓐᓇ ᐊᖏᔪᒻᒪᕆᐊᓗᒃ ᐊᒻᒪ ᓇᒻᒪᖏᑦᑐᒻᒪᕆᐊᓗᒃ ᓱᓕᓪᓚᕆᑦᑐᖅ ᐊᒥᓱᕈᖅᐸᓪᓕᐊᓯᒪᑐᐃᓐᓇᑐᑦ ᐅᑭᐅᓄᑦ ᖁᓕᓄᑦ ᐊᒻᒪ ᐊᓯᔾᔨᖅᑕᐅᔭᕆᐊᓕᒃ.

ᐅᓗᒻᒥ, ᐃᓕᓴᕆᓪᓗᕈ ᓄᓇᕐᔪᐊᓕᒫᒥ ᐳᕙᓪᓗᓐᓇᖅᑐᒧᑦ (TB) ᐅᓪᓗᖓᓄᑦ, ᒥᓂᔅᑕ ᓄᓇᖃᖅᑳᖅᑐᓕᕆᓂᕐᒧᑦ, ᔭᐃᓐ ᕕᓪᐹᑦ, ᐊᒻᒪ ᐊᖓᔪᖅᑳᕆᔭᐅᔪᖅ ᐃᓄᐃᑦ ᑕᐱᕇᑦ ᑲᓇᑕᒥ (ITK), ᓇᑖᓐ ᐆᐱᑦ, ᐅᖃᖅᑐᐃᓐᓇᐅᕘᒃ ᐊᖏᖅᓯᒪᓂᕆᔭᖏᓐᓂᒃ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒥ ᐃᓄᐃᑦ ᓄᓇᓕᒫᖓᓂ ᑎᑭᓪᓗᒍ 2030, ᐊᒻᒪ ᐊᐃᑦᑑᑕᐅᓲᒥᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᒥ (TB) ᐱᑕᖃᕈᓐᓃᕐᔫᒥᓗᓂ 50 ᐳᓴᓐᑎᒥ ᑎᑭᓪᓗᒍ 2025. ᑕᒪᓐᓇ ᑎᑭᐅᒪᔭᐅᑦᓯᐊᓛᖅᑐᖅ ᑕᕝᕘᓇ ᐱᑕᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒧᑦ ᖃᓄᐃᓕᐅᕆᐊᕐᓂᕐᒧᑦ ᐊᑐᐊᒐᕐᒧᑦ ᓯᕗᒨᕈᑕᐅᔪᖅ ᑕᐃᒃᑯᐊᖑᓚᐅᖅᓯᒪᔪᓄᑦ ᐅᖃᐅᓯᐅᓚᐅᖅᓯᒪᔪᓄᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᒧᑦ (TB) ᐱᓕᕆᔨᒻᒪᕆᒃᑯᖏᓐᓄᑦ.

ᓯᕗᓪᓕᐅᑎᔭᐅᖁᔭᐅᔪᑦ ᐃᓅᔪᓐᓃᖅᑐᖃᕈᓐᓃᕐᓗᓂ ᑐᕌᖓᔪᓂ ᐅᑕᖅᑭᑯᑖᓐᓂᐅᕙᑦᑐᒥᑦ ᓱᖅᑯᐃᖅᑕᐅᓇᓱᓐᓂᐅᔪᒥᑦ ᐊᒻᒪ ᐳᕙᓪᓗᓐᓇᖅᑐᖅᑕᖃᕈᓐᓃᕐᓗᓂ (TB) ᓄᑕᕋᓛᓂᑦ. ᐱᑕᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒧᑦ ᐸᕐᓇᐅᑏᑦ ᐊᑐᓂ ᑎᓴᒪᐅᔪᓂ ᐃᓄᐃᑦ ᐊᕕᑦᑐᖅᓯᒪᔪᖁᑎᖏᓐᓂᒃ ᑲᑎᓪᓗᒋᑦ ᐃᓄᐃᑦ ᓄᓇᖕᒐᐅᓂᕋᖅᑕᐅᔪᖅ ᐋᖅᑭᑦᓱᖅᑕᐅᓛᖅᑐᖅ ᐊᒻᒪ ᑐᕌᖓᑦᓯᐊᕐᓗᓂ ᐊᕕᑦᑐᖅᓯᒪᔪᑦ ᓴᙱᓂᕆᔭᖏᓐᓄᑦ ᐊᒻᒪ ᐱᔭᕆᐊᓕᖏᓐᓄᑦ. ᐊᕕᑦᑐᖅᓯᒪᔪᑦ ᐸᕐᓇᐅᑎᖏᑦ ᐃᓚᖃᕐᓂᐊᖅᑐᑦ ᓴᙱᓂᖅᓴᓂ ᐃᓄᓕᒫᓄᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ ᐱᓕᕆᐊᑦᓴᓂ ᐊᒻᒪ ᐃᓐᓄᑦᓱᐃᓂᕐᒥᑦ ᓄᓇᓕᐅᔪᓂ ᓱᖅᑯᐃᖅᑕᐅᓵᓕᖃᑦᑕᕐᓂᐊᕐᒪᑕ, ᑐᕌᖓᓕᕐᓗᓂ ᐃᓅᓕᓴᖅᑕᐅᓴᕋᐃᓂᕐᒧᑦ ᐊᐃᑦᑑᑕᐅᓲᒥᒃ ᐳᕙᓪᓗᑦᑐᓄᑦ (TB) ᐊᒻᒪ ᓯᓂᓐᓂᕋᖅᑕᐅᔪᒧᑦ ᐳᕙᓪᓗᑦᑐᓄᑦ (TB) ᐋᓐᓂᐊᒧᑦ. ᐅᔾᔨᕈᓱᓕᖅᑎᑦᓯᓂᕐᒥᑦ ᐊᑦᓱᕉᑎᖃᕐᓂᐊᖅᑐᑦ ᑐᑭᓯᐅᒪᓂᖅᓴᐅᓕᖁᓪᓗᒋᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᒥ (TB) ᐊᐃᑦᑐᐃᙱᓐᓂᖅᓴᐅᖁᔨᒧᑦ ᐊᒻᒪ ᑎᒃᑯᐊᖅᑕᐅᔪᒪᙱᒧᑦ.

ᑎᑭᐅᒪᓂᐊᕐᓗᑎ ᑖᒃᑯᓂᖓ ᖃᓂᑦᑐᑯᓗᓐᓂ ᐅᓪᓘᔪᓂ, ᐱᓕᕆᐊᖃᒻᒪᕆᓐᓂᐊᖅᑐᑦ ᐃᓅᓯᕐᒨᖓᔪᓂ ᐊᑲᐅᙱᓕᐅᕈᑎᓂ ᐊᒻᒪ ᐱᐅᓯᕚᓪᓕᖅᑕᐅᓗᑎ ᐃᓄᐃᑦ ᐃᓅᓯᖏᓐᓂ ᐊᑦᑐᐊᖃᓯᐅᑎᔪᓂ ᐳᕙᓪᓗᓐᓇᖅᑐᒧᑦ (TB); ᓲᕐᓗ ᐃᓪᓗᓕᕆᓂᖅ, ᓂᕆᔭᑦᓴᖃᑦᓯᐊᕐᓂᖅ ᐊᒻᒪ ᓂᕿᑦᓯᐊᕙᓕᕆᓂᖅ, ᐊᑐᐃᓐᓇᖃᕐᕕᐅᓂᕐᒥᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ ᐱᔨᑦᓯᕋᐅᑎᓂ ᐊᒻᒪ ᐃᓱᒪᓕᕆᓂᕐᒧᑦ ᖃᓄᐃᙱᑦᓯᐊᕆᐊᕐᓂᕐᒥᑦ.

ᑲᓇᑕᐅᑉ ᒐᕙᒪᖓ ᐊᒻᒪ ᐃᓄᐃᑦ ᑕᐱᕇᑦ ᑲᓇᑕᒥ ᖃᐅᔨᒪᔫᒃ ᐊᒥᓱᓄᑦ ᐱᓕᕆᔭᐅᔭᕆᐊᓕᒃ, ᑲᑐᔾᔨᖃᑎᒌᓂᒃᑯᑦ, ᐊᒻᒪ ᐃᓄᓐᓄᑦ ᐊᐅᓚᑕᐅᓗᓂ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒧᑦ (TB) ᑕᐃᒪᐃᒋᐊᖃᓪᓚᕆᑦᑐᖅ ᑲᔪᓯᓂᖃᑦᓯᐊᕐᓂᐊᕈᓂ.

ᑕᒪᑐᒪ ᐊᕐᕌᒍᒥ ᑐᕌᒐᕆᔭᖓ ᓄᓇᕐᔪᐊᓕᒫᒥ ᐳᕙᓪᓗᓐᓇᖅᑐᒧᑦ (TB) ᐅᓪᓗᖓᓂ ᑖᓐᓇᐅᔪᖅ “ᐱᒍᒪᔪᑦ − ᓯᕗᓕᖅᑎᑦᓴᓂᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑐᒧᑦ ᓄᓇᕐᔪᐊᕐᒧᑦ”. ᑲᓇᑕᐅᑉ ᒐᕙᒪᖓ ᐊᒻᒪ ᐃᓄᐃᑦ ᑕᐱᕇᑦ ᑲᓇᑕᒥ (ITK) ᐱᓕᕆᖃᑎᒌᑦᓯᐊᓛᖅᑑᒃ ᓯᕗᓕᖅᑎᐅᓗᑎ ᑲᒪᒋᔭᖃᕐᓂᕐᒥᑦ ᐃᓅᓯᕐᒨᖓᔪᓂ ᓈᒻᒪᙱᓗᐊᖅᑐᓂᑦ ᐳᕙᓪᓗᓐᓂᕐᒧᑦ (TB) ᑲᔪᓰᓐᓇᖅᑎᑦᓯᔪᓂ, ᐊᒻᒪ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒥ ᐃᓄᐃᑦ ᓄᓇᓕᒫᖓᓂ ᑎᑭᓪᓗᒍ 2030.

ᐅᖃᐅᓰᑦ

“ᐃᓕᓴᕆᔪᒪᔭᕋ ᓯᕗᓕᖅᑎᒻᒪᕆᐅᔪᑦ ᐊᒻᒪ ᐃᑲᔪᖅᓱᒻᒪᕆᓐᓂᕆᔭᖏᓐᓂᒃ ᑖᒃᑯᐊ ᐃᓄᐃᑦ ᑕᐱᕇᑦ ᑲᓇᑕᒥ (ITK), ᑖᒃᑯᐊᓗ ᑲᓇᑕᐅᑉ ᓂᒋᐊᓂ ᐊᕕᑦᑐᖅᓯᒪᓂᐅᔪᓂ ᐊᒻᒪ ᐅᑭᐅᖅᑕᖅᑐᒥ ᐊᕕᑦᑐᖅᓯᒪᓂᐅᔪᓂᑦ ᒐᕙᒪᒋᔭᐅᔪᓂ. ᑲᓇᑕᐅᑉ ᒐᕙᒪᖓ ᐊᒻᒪ ᐃᓄᐃᑦ ᑕᐱᕇᑦ ᑲᓇᑕᒥ ᐊᔪᖏᓐᓂᓕᒫᖏᓐᓂ ᐱᓕᕆᓂᐊᖅᑐᑦ ᐊᖏᖅᓯᒪᓂᕆᔭᖏᓐᓂᒃ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒥ ᐃᓄᐃᑦ ᓄᓇᓕᒫᖓᓂ ᑎᑭᓪᓗᒍ 2030. ᑕᐃᒫᑎᒋᐊᓗᒃ ᐊᑯᓂᐅᑎᒋᔪᒥ ᐅᓪᓗᒥᒧᑦ ᑎᑭᐅᑎᓪᓗᐊᓚᐅᙱᒃᑲᓗᐊᖅᑐᒍᑦ ᐊᒻᒪ ᐱᓕᕆᔪᒪᓪᓚᕆᑦᑐᒍᑦ ᓯᕗᒨᖅᐸᓪᓕᐊᓗᑕ ᐸᕐᓇᐅᑎᖃᕐᓗᑕ ᓄᓇᓕᓐᓄᑦ ᐱᒋᔭᐅᔪᒥ ᐊᒻᒪ ᓄᓇᓕᓐᓄᑦ ᐊᐅᓚᑕᐅᔪᒥ ᐊᒻᒪ ᑐᕌᖓᖃᓯᐅᑎᓗᓂ ᑲᒪᑦᓯᐊᕐᓂᕐᒥᑦ ᐃᓅᓯᕐᒨᖓᔪᓂᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ.”

ᒪᓕᒐᓕᐅᖅᑎᕐᔪᐊᖅ ᔭᐃᓐ ᕕᓪᐹᑦ, ᓘᑦᑖᒻᒪᕆᒃ, ᑲᑎᒪᔨᒻᒪᕆᒃ, ᒪᓕᒐᓕᐅᖅᑎᕐᔪᐊᖅ.
ᒥᓂᔅᑕ ᓄᓇᖃᖅᑳᖅᑐᓄᑦ ᐱᔨᑦᑎᕋᑦᑎᒃᑯᓐᓄ

“ᑕᐃᒪᐃᒍᓐᓇᖅᑐᒍ ᐊᒻᒪ ᑕᐃᒪᐃᒋᐊᖃᖅᑐᒍᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓗᑕ ᐊᑐᓂ ᐃᓄᐃᑦ ᓄᓇᓕᓕᒫᖏᓐᓂ ᑲᓇᑕᒥ. ᐃᓄᐃᑦ ᐊᑦᓱᕈᖅᓯᒪᔪᑦ ᑖᑦᓱᒧᖓ ᑕᐃᒪᐃᒍᑕᐅᒋᐊᑐᙱᑦᑐᒥ ᐊᒻᒪ ᐱᔪᓐᓃᕈᑕᐅᒍᓐᓇᖅᑐᒥ ᐋᓐᓂᐊᒥ, ᐊᒻᒪ ᒐᕙᒪᒃᑯᑦ ᐊᑦᓱᕉᓴᖅᑎᑦᓯᓂᕆᓚᐅᖅᑕᖏᓐᓂᒃ ᑕᐃᒪᐃᓕᖓᑯᑖᓗᐊᓕᖅᑐᖅ ᑕᒪᐃᓐᓄᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᒻᒪ ᖃᓄᐃᙱᑦᓯᐊᕐᓂᐅᔪᒧᑦ ᓄᓇᓕᑦᑎᓐᓄᑦ, ᐊᑯᓂᓗᐊᕌᓗᒃ. ᐅᐱᒍᓱᑉᐸᖓ ᐅᓪᓗᒥᐅᔪᖅ ᑖᑦᓱᒥᖓ ᐅᖃᐅᓯᖃᕐᓂᕐᒥᑦ ᑐᕌᒐᖃᕐᓂᕐᒥᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᕐᓗᓂ (TB) ᐃᓄᓐᓂᑦ. ᐃᓄᐃᑦ ᓯᕗᓕᖅᑏᑦ ᑲᓇᑕᒥ ᓵᑕᐅᔪᓐᓇᖅᓯᑎᑦᓯᓂᐊᖅᑐᑦ ᑕᒪᓐᓇ ᐳᕙᓪᓗᓐᓇᖅᑐᖅ (TB), ᐊᑕᓗᐊᓕᕐᓂᖓ ᐃᓅᓯᕐᒧᑦ ᐊᔾᔨᒌᑎᑕᐅᙱᓗᐊᕐᓂᕐᒧᑦ, ᑲᒪᒋᔭᐅᑦᓯᐊᕐᓗᓂ ᐊᑕᖏᐅᒪᑦᓯᐊᖅᑐᒥᓪᓗ.”

ᓇᑖᓐ ᐆᐱᑦ
ᐊᖓᔪᖅᑳᖅ ᐃᓄᐃᑦ ᑕᐱᕇᑦ ᑲᓇᑕᒥ (ITK)

“ᐊᓕᐊᓇᐃᒍᓱᑦᑐᖓ ᑖᒃᑯᐊ ᓄᓇᕗᑦ ᒐᕙᒪᒃᑯᑦ, ᐃᑲᔪᖅᓱᖅᑕᐅᓪᓗᑎ ᑲᓇᑕᐅᑉ ᒐᕙᒪᖓᓄᑦ, ᓄᓇᓕᖕᓂ ᒐᕙᒪᒃᑯᓐᓂᓪᓗ ᐱᔨᑦᑎᕋᖅᑎᒃᑯᑦ ᐱᓕᕆᕝᕕᖓ ᐊᒻᒪ ᐊᓯᖏᑦ ᑲᑐᔾᔨᖃᑕᐅᔪᑦ, ᐊᓪᓗᕆᐊᖅᓯᒪᒻᒪᕆᑦᑐᑦ ᑕᒪᑐᒪ ᐊᕐᕌᒍᒥ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒧᑦ ᓄᓇᖁᑎᒋᔭᑦᑎᓐᓂ. ᐊᐅᓚᓂᕆᔭᖓ ᐱᓇᓱᐊᕈᓯᕐᓄᑦ ᑎᓴᒪᐅᔪᙱᒑᖅᑐᓄᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᒧᑦ (TB) ᖃᐅᔨᓴᕐᓂᐅᑲᐃᓐᓇᖅᑐᒥ ᐊᑕᐅᓯᕐᒥ ᓄᓇᓕᐅᔪᒥ ᐅᒃᑑᑎᐅᕗᖅ ᖃᓄᐃᓕᐅᖅᑐᖃᕈᓐᓇᕐᒪᖔᖅ ᕿᓚᒻᒥᐅᔪᒃᑯᑦ ᐱᓕᕆᖃᑎᒌᑦᓯᐊᕈᑦᑕ. ᓂᕆᐅᓐᓂᖃᖅᑐᖓ ᓯᕗᓂᑦᓴᒥ ᐱᓕᕆᖃᑎᒌᑦᓯᐊᖏᓐᓇᕐᓗᑕ ᐃᑲᔫᑎᖃᑦᓯᐊᕐᓂᐊᖅᑐᒥ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᒻᒪ ᖃᓄᐃᙱᑦᓯᐊᖅᑐᓕᕆᓂᕐᒧᑦ ᓄᓇᕗᒻᒥᐅᓕᒫᓄᑦ.”
ᒪᓕᒐᓕᐅᖅᑎ ᐹᑦ ᐊᕐᓇᒃᑲᖅ
ᒥᓂᔅᑕ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ, ᓄᓇᕗᒻᒥ ᒐᕙᒪᒃᑯᑦ

“ᓄᓇᑦᓯᐊᕗᑦ ᒐᕙᒪᖓ ᐊᖏᖅᓯᒪᔪᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᖅᑕᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒧᑦ (TB) ᐊᒻᒪ ᖃᓄᐃᓕᐅᕆᐊᖅᓯᒪᒻᒪᕆᑦᑐᑦ ᑲᒪᒋᔭᖃᕐᓂᕐᒥᑦ ᑖᑦᓱᒥᖓ ᐋᓐᓂᐊᖑᔪᒥ ᓄᓇᓕᑦᑎᓐᓂ, ᐱᒋᐊᖅᑎᑦᓯᓂᒃᑯᓪᓗ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒧᑦ ᐸᕐᓇᐅᑎᒥ “ᐳᕙᓪᓗᒍᓐᓃᖅᑎᑦᓯᓂᕐᒥᑦ ᓄᓇᑦᓯᐊᕗᒻᒥ − ᒫᙵ ᑖᕗᖓ.” ᖃᐅᔨᒪᑦᑎᐊᖅᑐᒍᑦ ᐱᑕᖃᕈᓐᓃᖅᑎᑦᓯᑦᑎᐊᕐᓂᖅ ᑎᑭᐅᒪᔭᐅᓐᓂᐊᖅᑐᖅ ᑭᓯᐊᓂ ᒐᕙᒪᑐᖃᒃᑯᑦ ᐊᒻᒪ ᑲᓇᑕᐅᑉ ᓂᒋᐊᓂ ᐊᕕᑦᑐᖅᓯᒪᓂᐅᔪᑦ ᑲᑐᔾᔨᖃᑎᒌᑦᑎᐊᕈᑎ, ᓄᓇᓕᒻᒥᓪᓗ ᐱᓕᕆᖃᑎᖃᕐᓗᑎ ᐊᒻᒪ ᐃᑲᔪᖅᓱᕐᓗᑎ. ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᖅ (TB) ᐊᔾᔨᐅᙱᑦᑐᓂ ᐱᓕᕆᐊᖃᕆᐊᓖᑦ ᐊᒻᒪ ᐸᕐᓇᐅᑎᓂᑦ, ᐃᓚᒋᓪᓗᓂᒋᑦ ᐃᓅᓯᕐᒨᖓᔪᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ, ᓲᕐᓗ ᐃᓪᓗᓕᕆᓂᖅ, ᓂᕆᔭᑦᓴᖃᑦᓯᐊᕐᓂᖅ, ᐃᓅᓯᕐᒧᑦ ᐃᑲᔫᑎᑦᓴᑦ ᐊᒻᒪ ᖃᓄᐃᙱᑦᓯᐊᖅᑐᒥ ᓄᑕᖅᑲᑦ ᐱᕈᖅᐸᓪᓕᐊᓂᖏᓐᓄᑦ.”
ᐊᖓᔪᖅᑳᖅ ᓚᒻᑉ, ᓄᓇᑦᓯᐊᕗᑦ ᒐᕙᒪᖓ

“ᒫᓐᓇᐅᔪᖅ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒥᑦ ᓯᕗᓪᓕᐅᔾᔭᐅᔭᕆᐊᖃᓪᓚᕆᑦᑐᖅ. ᑕᐃᒪᐃᑦᑐᖃᓚᐅᖅᓯᒪᙱᑦᑐᖅ ᐱᓕᕆᖃᑎᒌᔪᒪᓪᓗᑎ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᔪᒪᓂᕐᒧᑦ (TB) ᑲᓇᑕᒥ. ᑕᒪᓐᓇ ᑐᑭᓯᓇᑦᓯᐊᖅᑐᖅ ᓄᓇᓕᓐᓂ ᓯᕗᓕᖅᑎᐅᔪᓄᑦ ᐊᒻᒪ ᐱᓕᕆᐊᕆᔭᐅᕙᓪᓕᐊᔪᓄᑦ, ᐊᒻᒪ ᐱᒍᒪᓂᕆᔭᖏᑦ ᒐᕙᒪᓕᒫᓂᑦ ᐊᒻᒪ ᑲᓇᑕᒥ ᓄᓇᖃᖅᑳᖅᓯᒪᔪᓄᑦ ᑲᑐᔨᖃᑎᒌᖑᔪᓄᑦ. ᒫᓐᓇᐅᔪᖅ ᐃᑲᔪᖅᓱᑦᑎᐊᕆᐊᖃᖅᑐᒍᑦ ᐃᖏᕐᕋᓂᐅᔪᒥᑦ.”
ᓘᑦᑕᖅ ᑐᕇᓴ ᑖᒻ
ᑲᓇᑕᐅᑉ ᐃᓄᓕᒫᓄᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᔨᒻᒪᕆᖓ

“ᓄᓇᓕᐅᔪᑦ ᐃᓚᖏᑦ ᓄᓇᕕᒻᒥ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᖅᓯᒪᒻᒪᕆᑦᑐᑦ ᐅᑭᐅᓂᑦ ᐊᑐᕋᑖᖅᑐᓂᑦ. ᑕᒪᓐᓇ ᐅᖃᐅᓯᕆᔭᐅᔪᖅ ᐱᐅᔪᒻᒪᕆᐊᓗᒃ ᐃᑲᔪᖅᓱᓂᕐᒧᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒧᑦ ᓄᓇᓕᑦᑕ ᓯᕗᓕᖅᑎᖏᓐᓂ ᐱᓕᕆᖃᑎᖃᕐᓗᑕ ᓴᖅᑮᓂᕐᒥᑦ ᐃᓄᓐᓄᑦ ᑲᒪᒋᔭᐅᔪᒧᑦ ᐸᕐᓇᐅᑎᒥ. ᐅᑉᐱᕈᓱᑦᑐᖓ ᐳᕙᓪᓗᓐᓇᖅᑐᖅᑕᖃᕈᓐᓃᕈᓐᓇᖅᑐᖅ ᑖᒃᑯᐊ ᐊᕕᑦᑐᖅᓯᒪᔪᑦ ᖃᓄᐃᓕᐅᕆᐊᕐᓂᕐᒧᑦ ᐸᕐᓇᐅᑎᕗᑦ ᐃᓚᓕᐅᑎᓯᒪᑉᐸᑕ ᐃᓄᐃᑦ ᐊᑐᖅᓯᒪᔭᑐᖃᖏᓐᓂ ᐊᒻᒪ ᑕᐅᑐᑦᑕᒥᓂ.”

ᒥᓂ ᒍᕋᐃ, ᑐᑭᒧᐊᖅᑎᑦᓯᔨᒻᒪᕆᒃ ᓄᓇᕕᒻᒥ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᔨᒃᑯᓐᓂ ᐊᒻᒪ ᐃᓄᓕᕆᔨᒃᑯᓐᓂ (NRBHSS)

ᓇᐃᑦᑑᑏᑦ ᓱᓕᔪᑦ

• ᐳᕙᓪᓗᓐᓇᖅᑐᖅ ᐋᓐᓂᐊᖑᔪᖅ ᐊᑦᑐᐃᓂᖃᕐᓂᖅᓴᐅᓲᖅ ᐃᓄᐃᑦ ᐊᒻᒪ ᐊᓪᓚᐃᑦ ᓄᓇᓕᖏᓐᓂ ᑕᑯᓐᓇᖃᓯᐅᑎᓗᒍ ᑲᓇᑕᒥ ᐃᓅᓂᑰᔪᑦ, ᓄᓇᖃᖅᑳᖅᓯᒪᖏᑦᑐᓄᑦ. ᐳᕙᓪᓗᓐᓇᖅᑐᖅ (TB) ᐃᓅᓕᓴᖅᑕᐅᔪᓐᓇᖅᑐᖅ ᐊᒻᒪ ᐱᔪᓐᓃᖅᑎᑕᐅᔪᓐᓇᖅᑐᑦ ᐄᔭᒐᕐᓄᑦ.
• ᑎᒃᑯᐊᖅᓯᓂᖅ ᐊᒻᒪ ᐊᑭᕋᖅᑐᕐᓂᖅ ᓄᖅᑲᖓᕈᑕᐅᔪᒻᒪᕆᐊᓗᐃᑦ ᓱᓕ ᐳᕙᓪᓗᓐᓇᖅᑐᒧᑦ (TB) ᑲᒪᒋᔭᖃᕐᓂᕐᒥᑦ ᐊᒻᒪ ᑕᐃᒪᐃᑦᑐᑖᖅᑕᐃᓕᒪᓂᕐᒧᑦ, ᑭᒃᑯᑐᐃᓐᓇᐃᑦ ᖃᐅᔨᓴᖅᑕᐅᓇᓵᓕᑐᐃᓐᓇᕆᐊᓖᑦ.
• ᐅᐊᑦᓯᐊᕉᑎᓪᓗᒍ ᐊᑦᓱᕉᑕᐅᓚᐅᖅᓯᒪᔪᖅ ᐃᓄᐃᑦ ᐊᐅᓪᓚᖅᑎᑕᐅᖃᑦᑕᖅᑎᓪᓗᒋᑦ ᓄᓇᓕᖏᓐᓂ ᐋᓐᓂᐊᕕᓕᐊᖅᑎᑕᐅᓪᓗᑎ ᖃᓪᓗᓈᓄᑦ ᐃᓅᓕᓴᖅᑕᐅᔭᖅᑐᖅᑐᑎ, ᐊᖏᕐᕋᙱᓴᐃᓐᓇᖅᐸᑦᓱᑎ ᑕᒪᓐᓇ ᓄᖅᑲᖓᕈᑕᐅᔪᒻᒪᕆᐅᓲᖅ ᐋᓐᓂᐊᕕᒻᒧᑦ ᑲᒪᒋᔭᐅᔭᖅᑐᓂᕐᒧᑦ.
• ᑲᓇᑕᐅᑉ ᒐᕙᒪᖓ ᐊᖏᖅᓯᒪᔪᑦ ᐃᑲᔪᖅᓱᕈᒪᓪᓗᑎ ᐊᒻᒪ ᐱᓕᕆᖃᑎᖃᕈᒪᓪᓗᑎ ᐃᓄᐃᑦ ᑲᑐᔾᔨᖃᑎᒌᒃᑯᖏᓐᓂ, ᓄᓇᓕᖏᓐᓂ, ᑲᓇᑕᐅᑉ ᓂᒋᐊᓂ ᐊᕕᑦᑐᖅᓯᒪᔪᓂ ᐊᒻᒪ ᐅᑭᐅᖅᑕᖅᑐᒥ ᐊᕕᑦᑐᖅᓯᒪᔪᓂ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᔨᒃᑯᖏᓐᓂ, ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᖃᐅᔨᒪᔨᑕᕐᓂ ᐊᓯᖏᓐᓂᓪᓗ ᑲᑐᔾᔨᖃᑎᒋᔭᐅᔪᓂᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᕈᓐᓃᖅᑎᑦᓯᓂᕐᒧᑦ (TB) ᐊᖏᔪᒻᒪᕆᐊᓘᓪᓗᓂ ᐃᓄᓕᒫᓄᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ ᐅᓗᕆᐊᓇᕐᓂᖓᓂ ᐃᓄᐃᑦ ᓄᓇᖕᒐᓂ. ᑕᒪᓐᓇ ᐃᓚᖃᖅᑐᖅ ᑲᒪᑦᓯᐊᓂᕐᒥᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒥᑦ ᐊᒻᒪ ᐃᓅᓯᕐᒧᑦ−ᒪᑭᒪᐅᑏᓪᓗ ᐊᑦᑐᐃᖃᓯᐅᑎᔪᓂ ᐃᓄᐃᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᒻᒪᕆᓐᓂᕆᔭᖏᓐᓂ.
• ᑮᓇᐅᔭᑦ ᐊᑐᖅᑐᑦᓴᓂᑦ 2018-ᒥ ᒫᓐᓇᕈᓘᔪᔪᖅ ᐅᖃᔪᔪᑦ $27.5 ᒥᓕᔭᓐᓂᒃ ᐅᑭᐅᓄᑦ ᑕᓪᓕᒪᓄᑦ ᐃᑲᔪᖅᓱᕈᒪᓪᓗᑎ ᐱᓕᕆᐊᕆᔭᐅᔪᓂᑦ ᐃᓄᐃᑦ ᓄᓇᖕᒐᓂ. ᑕᒪᓐᓇ ᐃᓚᖃᖅᑐᖅ ᑮᓇᐅᔭᖃᖅᑎᑦᓯᓂᕐᒥᑦ ᑕᐃᒪᐃᑦᑕᐃᓕᒪᑎᑦᓯᓂᕐᒥᑦ, ᖃᐅᔨᓴᕐᓂᕐᒧᑦ, ᓱᖅᑯᐃᖅᓯᓂᕐᒧᑦ ᐊᒻᒪ ᐃᓅᓕᓴᐃᓂᕐᒥᑦ ᐳᕙᓪᓗᑦᑐᓄᑦ (TB) ᐊᒻᒪ ᓯᓂᓐᓂᕋᖅᑕᐅᔪᒥ ᐳᕙᓪᓗᑦᑐᓄᑦ (TB) ᐋᓐᓂᐊᒧᑦ.
• ᑕᒪᓐᓇ ᐃᓚᒋᖃᓯᐅᑎᔭᖓ $509.5 ᒥᓕᔭᓐᓂᒃ ᑮᓇᐅᔭᕐᓂᒃ ᐊᑐᖅᑐᑦᓴᓂᑦ 2018-ᒥ ᐱᓕᕆᖃᑎᖃᕐᓂᕐᒧᑦ ᐃᓄᓐᓂ ᐊᒻᒪ ᐊᓯᖏᓐᓂ ᑲᑐᔾᔨᖃᑎᒋᔭᐅᔪᓂ ᓴᙱᓂᖅᓴᐅᓕᖁᓪᓗᒋᑦ ᐃᓄᓕᒫᓅᖓᔪᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ ᐱᓕᕆᐊᖑᔪᓂ, ᓄᐊᑦᑎᓂᕐᒧᑦ ᑎᑎᕋᖅᓯᒪᔪᓂ ᖃᐅᔨᓴᖅᑕᐅᓂᑯᓂ ᑕᕝᕘᓇ ᐃᓄᓐᓂ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᕐᒧᑦ ᖃᐅᔨᓴᕐᓂᕐᒥᑦ, ᐃᓪᓗᑖᖅᑎᑦᓯᒃᑲᓐᓂᓂᕐᒧᑦ ᑲᒪᓂᕐᒧᑦ ᐃᓄᒋᐊᓗᐊᖃᑦᑕᕐᓂᕆᔭᖏᓐᓄᑦ ᐃᓄᐃᑦ ᓄᓇᓕᖏᓐᓂ, ᐊᒻᒪ ᐃᑲᔪᖅᓱᓂᕐᒧᑦ ᐃᖅᑲᓇᐃᔭᕐᓂᐅᔪᖅ ᐊᒻᒪ ᐃᖅᑲᓇᐃᔮᑦᓴᓄᑦ ᐱᓕᒻᒪᑦᓴᕐᓂᐅᔪᖅ.
• ᑕᒪᓐᓇ ᖄᒃᑲᓐᓂᐊᒎᖓᔪᖅ $240 ᒥᓕᔭᓐᓄᑦ ᐊᕐᕌᒍᓄᑦ ᖁᓕᓄᑦ ᐅᖃᐅᓯᕆᔭᐅᓚᐅᖅᑐᓂ ᑮᓇᐅᔭᑦ ᐊᑐᖅᑐᑦᓴᓂᑦ 2017-ᒥ ᐃᑲᔪᖅᓱᕈᒪᓪᓗᑎ ᐃᓪᓗᓕᕆᓂᐅᔪᒥᑦ ᓄᓇᕘᒥ.
• ᑕᕝᕙᓂ ᐅᑭᐅᖑᔪᒥ, ᑲᓇᑕᐅᑉ ᒐᕙᒪᖓ ᐃᑲᔪᖅᓱᓚᐅᖅᑐᖅ ᓄᓇᕗᑦ ᒐᕙᒪᒃᑯᑦ ᐊᐅᓪᓚᖅᑎᑦᓯᓂᕆᔭᖏᓐᓂᒃ ᖃᐅᔨᓴᕐᓂᐅᑲᐃᓐᓇᖅᑐᒥ ᓄᓇᕗᒻᒥ ᓄᓇᓕᐅᔪᒧᑦ ᑲᒪᒋᔭᖃᕐᓂᕐᒧᑦ ᓄᓇᓕᐅᔪᒥ ᐳᕙᓪᓗᓐᓇᖅᑐᒥ (TB) ᓯᐊᒻᒪᑉᐸᓪᓕᐊᕕᐅᔪᒻᒪᕆᒻᒥ. 40 ᐅᖓᑖᓄᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᔩᑦ ᒐᕙᒪᑐᖃᒃᑯᓐᓂ ᐊᒻᒪ ᑲᓇᑕᐅᑉ ᓂᒋᐊᓂ ᐊᕕᑦᑐᖅᓯᒪᓂᐅᔪᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᔨᒃᑯᖏᓐᓂ ᐃᑲᔪᖃᑕᐅᓚᐅᖅᑐᖅ. 90 ᐳᓴᓐᑎ ᐅᖓᑖᓄᑦ ᐃᓄᓕᒫᖑᔪᓂᑦ ᖃᐅᔨᓴᖅᑕᐅᔪᓐᓇᖅᑐᓂ ᖃᐅᔨᓴᖅᑕᐅᓚᐅᖅᑐᑦ ᐱᓇᓱᐊᕈᓯᕐᓄᑦ ᑎᓴᒪᐅᔪᙱᒑᖅᑐᓄᑦ ᐱᒋᐊᓚᐅᖅᑐᑦ ᕕᕝᕗᐊᓕ 2018-ᒥ. ᖃᐅᔨᔭᐅᓂᑯᑦ ᑕᐃᑲᙵ ᖃᐅᔨᓴᕐᓂᐅᑲᐃᓐᓇᖅᑐᒥ ᕿᒥᕐᕈᔭᐅᓛᖅᑐᖅ ᐊᒻᒪ ᐊᑐᓕᖃᓯᐅᑎᓗᑎ ᓯᕗᓂᑦᓴᒥ ᖃᓄᐃᓕᐅᕆᐊᕈᑕᐅᔪᓄᑦ ᐳᕙᓪᓗᓐᓇᖅᑐᖃᙱᔾᔫᒥᓕᖁᓪᓗᒋᑦ (TB) ᐃᓄᐃᑦ ᓄᓇᖕᒐᓂ.

ᑲᓲᒪᕝᕖᑦ ᑐᕌᖓᖃᓯᐅᑎᔪᑦ

ᐳᕙᓪᓗᓐᓇᖅᑐᒧᑦ ᐱᓕᕆᔨᒻᒪᕆᒃᑯᑦ

ᐃᓄᓐᓄ ᑐᕌᖓᔪᖅ ᐳᕙᓪᓗᓐᓇᖅᑐᒧᑦ ᐸᕐᓇᐅᑎ

ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᔨᒃᑯᑦ ᑲᓇᑕᒥ – ᐳᕙᓪᓗᓐᓂᖅ

ᐊᓪᓚᐃᑦ ᐊᒻᒪ ᐃᓄᐃᑦ ᐋᓐᓂᐊᖃᕐᓇᙱᑦᑐᓕᕆᓂᖅ – ᐳᕙᓪᓗᓐᓂᖅ

ᑲᓇᑕᒥ ᐊᐃᑐᕐᓗᓐᓇᖅᑐᓄᑦ ᐋᓐᓂᐊᓄᑦ ᐅᓂᒃᑳᖅ

ᐃᓄᐃᑦ ᑕᐱᕇᑦ ᑲᓇᑕᒥ (ITK) ᐃᓅᓯᕐᒧᑦ ᐊᔾᔨᒌᙱᑎᑕᐅᓂᕐᒧᑦ ᓇᓗᓇᐃᔭᐅᑎ